Next Article in Journal
Heat Stress Affects H3K9me3 Level at Human Alpha Satellite DNA Repeats
Next Article in Special Issue
Evaluation of the Ion AmpliSeq SARS-CoV-2 Research Panel by Massive Parallel Sequencing
Previous Article in Journal
PlantMirP-Rice: An Efficient Program for Rice Pre-miRNA Prediction
Previous Article in Special Issue
Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract
Article

Rapid Direct Nucleic Acid Amplification Test without RNA Extraction for SARS-CoV-2 Using a Portable PCR Thermocycler

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore
*
Author to whom correspondence should be addressed.
Received: 9 May 2020 / Revised: 2 June 2020 / Accepted: 16 June 2020 / Published: 18 June 2020
There is an ongoing worldwide coronavirus disease 2019 (Covid-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). At present, confirmatory diagnosis is by reverse transcription polymerase chain reaction (RT-PCR), typically taking several hours and requiring a molecular laboratory to perform. There is an urgent need for rapid, simplified, and cost-effective detection methods. We have developed and analytically validated a protocol for direct rapid extraction-free PCR (DIRECT-PCR) detection of SARS-CoV-2 without the need for nucleic acid purification. As few as six RNA copies per reaction of viral nucleocapsid (N) gene from respiratory samples such as sputum and nasal exudate can be detected directly using our one-step inhibitor-resistant assay. The performance of this assay was validated on a commercially available portable PCR thermocycler. Viral lysis, reverse transcription, amplification, and detection are achieved in a single-tube homogeneous reaction within 36 min. This minimizes hands-on time, reduces turnaround-time for sample-to-result, and obviates the need for RNA purification reagents. It could enable wider use of Covid-19 testing for diagnosis, screening, and research in countries and regions where laboratory capabilities are limiting. View Full-Text
Keywords: Point-of-care; Diagnostics; DIRECT-PCR; portable PCR; SARS-CoV-2; Covid-19 Point-of-care; Diagnostics; DIRECT-PCR; portable PCR; SARS-CoV-2; Covid-19
Show Figures

Figure 1

MDPI and ACS Style

Wee, S.K.; Sivalingam, S.P.; Yap, E.P.H. Rapid Direct Nucleic Acid Amplification Test without RNA Extraction for SARS-CoV-2 Using a Portable PCR Thermocycler. Genes 2020, 11, 664. https://0-doi-org.brum.beds.ac.uk/10.3390/genes11060664

AMA Style

Wee SK, Sivalingam SP, Yap EPH. Rapid Direct Nucleic Acid Amplification Test without RNA Extraction for SARS-CoV-2 Using a Portable PCR Thermocycler. Genes. 2020; 11(6):664. https://0-doi-org.brum.beds.ac.uk/10.3390/genes11060664

Chicago/Turabian Style

Wee, Soon K., Suppiah P. Sivalingam, and Eric P.H. Yap 2020. "Rapid Direct Nucleic Acid Amplification Test without RNA Extraction for SARS-CoV-2 Using a Portable PCR Thermocycler" Genes 11, no. 6: 664. https://0-doi-org.brum.beds.ac.uk/10.3390/genes11060664

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop